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Carcinogenesis: A Late Effect of Irreversible
Toxic Damage during Development
by Jerry M. Rice*:P
Intrauterine and early postnatal life are periods of exceptionally high susceptibility to certain
kinds of chemical carcinogens. The most potent known transplacental carcinogens are direct act-
ing alkylating agents. Most nonreactive compounds, which require enzymes for metabolic conver-
sion into chemically reactive "proximate carcinogens," are less effective because the required
enzymes are present at low levels in the fetus, and many proximate carcinogens are too reactive to
reach the fetus when formed in maternal tissues. Despite this, many carcinogens which require
metabolic activation are very active transplancentally, as the intrinsic susceptibility of rapidly
dividing fetal cells compensates effectively for comparatively low tissue levels of reactive
metabolites. Transplacental carcinogens of all kinds are most effective late in gestation, generally
after organogenesis has begun and after the period of greatest susceptibility to teratogens. Only a
small number ofknown carcinogens have been tested for transplacental carcinogenic activity.
The great majority of tumors induced transplacentally in the well-studied rodent and lago-
morph species (mouse, rat, Syrian hamster, and rabbit) have morphologic features ofadult, rather
than enibryonal, tissues. A given agent tends to induce in a given species largely the same types of
tumor wshen given transplacentally as when administered directly to postweaning animals, unless
its carcinogenic effect in the latter is ascribable to some peculiarity ofdistribution, metabolism, or
physiology. In a second species, the spectrum of tumors induced either before of after birth may
be quite different.
For bioassay of suspected carcinogens, the significance of perinatal carcinogenesis lies in the
facts that the fetal and preweaning rodent is an extremely sensitive indicator of carcinogenic ac-
tivity, and that the facile adaptibility of fetal cells to tissue culture and their rapid expression in
vitro of properties of neoplastic transformation make possible a rapid in vivo/in vitro screening
system for chemical carcinogens.
Introduction
That the newborn mouse is more susceptible
than adult mice to oncogenic veruses was firmly
established in the early 1950's by Gross (1). In
contrast, subsequent demonstrations of a
similarly heightened neonatal susceptibility to
chemical carcinogens were greeted with some
reserve (2), chiefly because the effect was not
always great and appeared not to be general.
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However, the relatively recent discovery of the
spectacular transplacental carcinogenic activity
of certain direct-acting alkylating agents, notably
ethylnitrosourea (ENU) (3), convincingly demon-
strated that the period ofpostembryonic develop-
ment was one of great intrinsic susceptibility to
chemical carcinogens. This susceptibility has
since been shown to apply not only to direct-
acting alkylating agents, but to a broad range of
other classes of chemical carcinogens as well
(3-27) (Table 1).
There are a few agents which have been shown
to be carcinogenic only in neonatal rodents, but
no carcinogens are known which act only on the
December 1976 133Table 1. Representative transplacental carcinogens: small
organic molecules.
Refer-
Compound Species Target Organ ence
Enzyme-independent alkylating agen
Methylnitrosourea Rat
Ethylnitrosourea Rat
Ethylnitrosourea Mouse
Ethylnitrosourea Hamster
Ethylnitrosourea Rabbit
n-Propylnitrosourea Rat
n-Butylnitrosoureaa Rat
Methylnitrosourethanb Rat
Methylazoxymethanol Rat
Dimethyl sulfate Rat
Diethyl sulfate Rat
Propane sulfone Rat
Methyl methane- Rat
sulfonate
Enzyme-dependent alkylating agents
Dimethylnitrosamine Rat I
Diethylnitrosamine Rat I
Diethylnitrosamine Mouse I
Diethylnitrosamine Hamster '
1,2-Diethylhydrazinec Rat I
Procarbazine, N- Rat I
isopropyl-a-(2-
methyl-hydrazino)-
p-toluamide
Azoethanec Rat I
Azoxyethanec Rat I
Cycasin, methylazoxy- Rat
methyl--p-D-glucoside
Polynuclear aromatic hydrocarbons
Benzo[a]pyrene Mouse I
7,12-Dimethylbenz[a]- Mouse I
anthracene
7,12-Dimethylbenz[a]- Rat I
anthracene
Estrogens
Diethylstilbestrol
Diethylstibestrol
Diethylstilbestrol
Miscellaneous
Ethyl carbamate
Aflatoxin
Human
Mouse
Hamster
Lts
Nervous system
Nervous system
Lung, liver
Nervous system
Kidney
Nervous system
Nervous system
Various
Various
Nervous system
Nervous system
Nervous system
Nervous system
Kidney
Kidney
Lungs, liver
Trachea
Nervous system
Nervous system
Nervous system
Nervous system
Various
Lung, skin
Lung, various
Nervous system,
kidney
Vagina
Vagina
Vagina
(4)
(3,4)
(5)
(6)
(7)
(8)
(8)
(9)
(10)
(11)
(11)
(12)
(13)
(14)
(15
(16)
(17)
(18)
(19)
(18)
(18)
(20)
Mouse Lung
Rat Liver
a Higher homologs are inactive.
b Intraplacental injection.
c The dimethyl homolog is inactive.
d Data of J. McLachlan, Proceedings of the Conference on
Transplacental Carcinogenesis, January 19-21, 1976, NCI
Monograph, in preparation.
' Data of M. Rustia, Proceedings of the Conference on
Transplacental Carcinogenesis, January 19-21, 1976, NCI
Monograph, in preparation.
fetus. The same factors of metabolism, genetics,
etc. which determine the carcinogenic activity of
a compound in postnatal animals also pertain to
the fetus, with the added complications for tran-
splacental carci-noigenesis- 9hathi a-Y-ta} placenta-
may modify the distribution and further
metabolism of a compound and its maternal
metabolites, determining exposures for fetal
tissues which may be both quantitatively and
qualitatively different from those sustained by
maternal tissues; (b) enzymes ofdrug metabolism
required for activation of potential carcinogens
may be absent and weakly or noninducible in fetal
tissues until just before birth; and (c) dif-
ferentiating and rapidly dividing fetal cells differ
from adult cells in their intrinsic susceptibility to
carcinogens. This paper will summarize certain
features of carcinogenesis in prenatal and early
postnatal life, chiefly in rodent species, which
should be of general interest to toxicologists.
More details can be found in recent reviews
(28-31).
Transplacental Carcinogenesis
Chemical Characteristics ofTransplacental
Carcinogens
The single most comprehensive generalization
currently accepted about most chemical car-
cinogens which are small nonpolymeric organic
molecules is that they act by forming covalent
bonds to intracellular target molecules. These
reactions are nucleophilic substitution reactions
in which the carcinogen is the "nucleus," or elec-
trically positive reactant, while the intracellular
receptor is an electron-rich entity, often a
heteroatom (N,O,S) with an unshared electron
pair (32) Under biological conditions such reac-
tions are usually irreversible. Some chemical car-
cinogens, notably the direct-acting alkylating
agents, can participate in such reactions without
metabolic modification, or spontaneously form
decomposition products which are intrinsically
reactive. Others, including the polynuclear
aromatic hydrocarbons, nitrosamines, aromatic
amines, and in general the vast majority ofknown
chemical carcinogens, require enzyme-mediated
structural alteration-or activation-to form
chemically reactive metabolites or "proximate
carcinogens." Transplacental carcinogens
generally (a) are direct-acting agents, (b) are ac-
tivated by enzymes present in fetal target
tissues, or (c) are transformed by maternal (or
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134placental) enzymes into reactive metabolites suf-
ficently stable to reach the fetus.
Direct-acting alkylating agents are the most ac-
tive known transplacental carcinogens (Table 1),
and of these, the most potent are the
alkylnitrosoureas. ENU, administered as a single
dose, induces neurogenic tumors in rats (3) and
lung tumors in mice (5), with an apparent ef-
ficiency 50 times as great in the fetal rat and 15
times as great in the fetal mouse as in adults
(Tables 2 and 3). The actual relative quantities of
carcinogen reaching fetal tissues relative to adult
tissues have not been accurately determined, but
preliminary data indicate that the dose to the
fetus is lower than that to adults. The fetus is
thus probably even more susceptible to ENU
than these figures indicate.
In the homologous series of n-alkyl-
nitrosoureas, maximal activity is found with
the ethyl and propyl compounds, while the
methyl and butyl compounds are distinctly less
active and higher homologs are inactive (4,8,31).
Only the methyl and ethyl derivatives of most
other classes of alkylating agents have been
studied; in all cases, ethylating agents were more
potent transplacental carcinogens than
methylating agents. Probably this reflects in part
an optimal combination of chemical reactivity
(which tends to decrease as alkyl chain length in-
creases) and solubility properties (oil/water par-
tition coeffecients tend to increase with in-
creasing alkyl chain length). Possession of a key
Table 2. Comparative oncogenic effects of direct-acting and
enzyme-dependent alkylating agents administered transpla-
centally to the fetus or directly to adults.
Species
(gestation Parameter of Refer-
Compound and dose period) carcinogenesis ence
Direct acting alkylating agent
Ethylnitrosourea, BD IX Rat Multiplicity of (3)
60mg/kg (23days) neurogenic
tumors
Ethylnitrosourea Swiss Multiplicity of (5)
60mg/kg mouse lung tumors
(21 days)
Enzyme-dependent alkylating agents
Dimethylnitrosamine, Rat Fraction ofrats (14)
1 mg/kg/day x 7 (22days) with kidney
tumors
Diethylnitrosamine, Syrian Fraction ofham- (33)
45mg/kg hamster sters with respi-
(15days) ratory tract tu-
mors (trachea,
larynx, lungs)
structural element (e.g., a nitrosamide group) is
thus not sufficientper se to confer transplacental
carcinogenic activity on a compound.
Biosynthesis ofReactive Intermediates or
"Proximate Carcinogens"
Enzyme-dependent alkylating agents, such as
the dialkylnitrosamines and the 1,2-
dialkylhydrazines, generally require enzyme-
mediated oxidative metabolism of the N-
dealkylase type for formation of proximate car-
cinogens (Fig. 1, pathways A and D). The for-
mation of a-hydroxy derivatives of the
dialkylnitrosamines has been inferred from the
fact that aldehydes are isolated, along with
alkylation products, from microsomal reaction
mixtures in vitro. The intermediates themselves,
such as methyl(hydroxymethyl)nitrosamine
[CH3N(NO)CH20H, DMN-OH] from dimethyl-
nitrosamine [CH3N(NO)CH3, DMN, Fig. 1, path
A, R=R=H] are too short-lived to isolate.
It is virtually certain that transplacental car-
cinogenic effects of such compounds are due to
formation of proximate carcinogenic metabolites
solely within fetal target tissues, where such en-
zymes are present at levels much lower than in
corresponding adult tissues (33). A common
result is that compounds such as DMN are active
only very late in gestation, and are less active in
the fetus than in the adult (14) (Table 3).
However, the principle that ethylating agents are
more effective transplacental carcinogens than
methylating agents applies also to enzyme-
dependent compounds. Diethylnitrosamine, sub-
ject to the same metabolic requirements as its
dimethyl homolog, is as least as effective tran-
splacentally in the Syrian hamster fetus as in the
adult (34) (Tables 2 and 3).
It has recently become possible to investigate
the modes of action of DMN more directly, follow-
ingthe synthesis ofmethyl (acetoxymethyl) nitro-
samine [CH3N(NO)CH20COCH3, DMN-OAc), the
stable acetyl derivative of its postulated active
metabolite, DMN-OH (35). DMN, when given to
rats in a single dose either to adults or transpla-
centally, induces renal tumors almost exclusive-
ly. DMN-OAc is readily hydrolyzed by esterases,
and was expected to produce tumors in a wide
variety of tissues as a consequence of local gener-
ation of DMN-OH. When given to rats in a single
intraperitoneal injection, however, it yielded in-
testinal tumors exclusively (36), which we believe
is due to its rapid destruction in rat serum and its
much greater stability in bile. The offspring of
December 1976 135Table 3. Comparative oncogenic effects ofdirect-acting and enzyme-dependent alkylating agents administered transplacentally
to the fetus ordirectly to adults."
Results by day oftreatment
Day Day Day Day Day Day Day Day Day Day Day Day Day Day
Ref. 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Adult
Ethylnitro- Rat (3) 0 0 0 0 0.1 1.4 1.2 1.6 1.9 2.4 2.7 2.4 2.7 2.4 0.06
sourea
Ethylnitro- Mouse (5) - - - - 0.3 - 5.5 9.5 26.5 21.3 11.8 - - - 1.8
sourea
Dimethyl- Rat (14) ( 0 ) ( 0.04 ) 0.79
nitrosamine
Diethylnitro- Syrian (33) 0 0 0 0 0.4 0.4 0.71 0.95 0.82
samine hamster
a Animals and dosages as detailed in Table 2.
N=O Enz.
H N02- 02-TPNH 'Nt
RCH2NCH2 - RCH2NCH2R' -.----.-RCH2N 0
A I
R'CO, ", Alkylation
-R'CHO
acromolecules
RCH2NHCNH2 -N H -.- -[RCH2-NN-OH]NH---P.RCH21+ + N2 + OH-
RCH2NI NH l-R'CHO H20
0 RCH20H
0 0
t 0-glucosidas t
RCH2N = NCHR' RCH2N = NCR'H
C
0 OH
Ius Enz. gluoose 02-TPNH
H H Enz. 0
I I (01 t
RCH2N - NCH2R -- RCH2N = NCH2R' D RCH2N = NCH2R' D
Metaboic pools
or excretion
FIGURE 1. Metabolic paths, some requiring enzymes, all of
which lead to a common reactive alkylating species from a
variety of transplacental carcinogens. Path A: secondary
amine dialkylnitrosamine alkyl-a
-alkanolnitrosamine; Path B: Alkylurea -
alkylnitrosourea; Path C: cycasin (R = H) - alkylazox-
yalkanol; Path D: 1,2-dialkylhydrazine - azoalkane
azoxyalkane -alkylazoxyalkanol. Reproduced by permis-
sion from Rice (29).
rats given DMN-OAc intravenously during the
last 10 days of pregnancy develop brain and kid-
ney tumors, and very rarely intestinal tumors
(Rice et al., in preparation). These results are
compatible with the postulate that the induction
of tumors by DMN reflects endogenous formation
of DMN-OH within affected organs, since the
stable "carrier" derivative, DMN-OAc, is clearly
capable of causing tumors in other organs if it is
able to reach them.
Cycasin (methylazoxymethyl-p-D-glucoside) is
a natural product, a constituent of the nut of the
cycad, Cycas circinalis. This substance is harm-
less when injected into adult rats; it is excreted
quantitatively in the urine. But if fed, the gluco-
side linkage is hydrolyzed by bacterial gluco-
sidases in the intestine, liberating the moderately
stable proximate carcinogen, methylazoxymeth-
anol (MAM; Fig. 1,pathC,R = R' = H). Cycasinand
MAM are both transplacental carcinogens in the
rat (10,20), the former when given orally. The
stability of MAM is much greater than that of
DMN-OH (note that the two are structural iso-
mers), which undoubtedly accounts for the wide
variety of tumors produced by both MAM and
cycasin when given transplacentally or to adults.
The failure of the carcinogens dimethylhydrazine
and azoxymethane to induce tumors transplacen-
tally except on the last day of gestation (37),
despite their potent activity in adults and their
required metabolism to MAM (Fig. 1, path D, R =
R' = H), is in marked contrast to the potent
transplacental carcinogenicity of diethylhydra-
zine, azoethane, and azoxyethane (18). The
stability of the proximate carcinogen cannot be
the limiting factor in this case. It is possible that
(a) fetal enzymes which readily metabolize the
ethyl homologs are less active toward methyl
substrates, and that enzymes which do act on the
methyl substrates do not appear until just before
birth or (b) MAM generated in maternal tissues
generally reacts in situ and is not as efficiently
released into the maternal blood stream as its
diethyl homolog. Neither of these possibilities
has been tested.
Many substances which are not alkylating
agents have demonstrable and sometimes
striking transplacental carcinogenic activity. The
predominance of alkylating agents in Table 1 is
probably more a reflection of investigators'
choices than of the true ratio of alkylating agents
to other kinds of transplacental carcinogens. The
polynuclear aromatic hydrocarbons, for example,
have drawn the attention of only a few
Environmental Health Perspectives 136laboratories. Benzo[a]pyrene (22), methylcholan-
threne (38), and 7,12-dimethylbenz[a]anthracene
(DMBA, 21) have all been shown to be weak
transplacental carcinogens in mice, inducing
predominantly lung tumors in low incidence.
When DMBA was eventually studied in the rat,
however, it was reported to be a highly effective
transplacental carcinogen for the nervous system
and kidneys (23), an observation we have con-
firmed and extended (S.R. Joshi, et al., in
preparation). The target organs in each species
were the same for the polynuclear aromatic
hydrocarbons as for alkylating agents. The exact
metabolic paths involved in activation of the
polynuclear aromatic hydrocarbons to proximate
carcinogens are not known, but are generally ac-
cepted to involve arene oxide intermediates
formed enzymatically (40). Whether the proxi-
mate carcinogens responsible for the transplacen-
tal carcinogenic activity of these compounds are
formed in fetal tissues or in adult tissues with
subsequent transfer to the fetus has not been
determined.
Diethylstilbestrol (DES) has the distinction of
being the only substance known to be a trans-
placental carcinogen in man (24). Its effects ap-
pear so far to be limited to the vagina and cervix,
the differentiation of which is modified by
estrogen. This effect has been demonstrated
recently in the mouse by J. McLachlan (in
preparation) and in the Syrian hamster by M.
Rustia (in preparation). In both rodent species
the female genital tract was also the only organ
system in which tumors developed. Although it is
possible to envision reasonable metabolic paths
which would convert DES into reactive
metabolites like those of the aromatic hydrocar-
bon carcinogens, so far no evidence has been
produced that such metabolites actually are
formed. It may be that the carcinogenic activity
of DES is ascribable entirely to its estrogenic ac-
tivity, and that its mechanism of action is fun-
damentally different from that of other organic
chemical carcinogens. This question is currently
under active investigation.
Histologic and Biologic Features ofTrans-
placentally Induced Tumors: Organotropisnm
Since certain pediatric tumors of man may be
present at birth and must therefore have arisen
during intrauterine life, transplacental car-
cinogenesis was originally looked upon as a
possible source of such neoplasms, many of which
are characterized by distinctively primitive
histologic patterns (e.g., neuroblastoma,
medulloblastoma, Wilms' tumor). This ap-
parently reasonable prediction, whatever its
validity with respect to man, is not confirmed by
experimental studies on rodents. The vast
majority of tumors induced transplacentally in
mice, rats, and Syrian hamsters are histologically
and histogenetically equivalent to human tumors
of adult life, and arise in these rodent species well
after sexual maturity is attained. Three-fourths
of all transplacentally induced neurogenic tumors
observed in rats in a large German series (41) of
over 1000 tumors were of the myelin-forming
cells: schwannomas (neurinomas), oligoden-
drogliomas, and mixed gliomas in which
neoplastic oligodendrocytes predominated. The
only tumors of the neuron series observed in this
species were olfactory esthesioneuroepithe-
liomas. No neuroblastic tumors of the retina,
adrenal medulla, or cerebellum were seen. In con-
trast, the mouse, in which neurogenic tumors are
much more difficult to induce, yields a few
cerebellar medulloblastomas (but no other
neuroblastic tumors) in response to neonatal (42)
exposure to ENU. Kidney tumors are readily in-
ducible in both species with many agents, either
transplacentally or after birth, but in the mouse
these are invariably of adult epithelial morphol-
ogy, while in the rat a variable but small propor-
tion of primitive nephroblastic tumors are seen.
In the rabbit the latter are much more common
(7). It appears that susceptibility to various em-
bryonal tumors is a characteristic which varies
from species to species, as in the case for many
other kinds ofinducible neoplasm.
A corollary to this axiom is that a given agent,
when administered transplacentally, frequently
induces entirely different kinds of tumors in a
series of closely related species (Table 1). There
is also a generaltendency for many different kinds
of agents to induce a characteristic neoplasm
or spectrum of neoplasms in a given species. Vir-
tually any transplacental carcinogen except DES
will produce lung tumors in mice, while the ner-
vous system and kidneys appear especially
vulnerable in rats.
Latency periods are not consistently shorter
for a given type oftumor when the inducing treat-
ment is administered to the fetus or neonate
rather than to an adult.
Carcinogenesis during Infancy
As previously noted many, but not all, car-
cinogens are more effective in newborn or very
young animals than in adults (2), despite the fact
December 1976 137that many of the drug metabolizing enzymes
required for carcinogen activation are present in
infant tissues at levels below those of adults.
Aflatoxin B, for example, is a potent liver car-
cinogen in adult rats and in several other species,
but adult mice are refractory to it; only newborn
and infant mice are highly susceptible (43). In-
terestingly, aflatoxin is a rather weak tran-
splacental carcinogen in the rat (27).
The changing patterns of enzyme activity
during fetal and early postnatal development do
not always result in a steadily increasing
capability to activate carcinogens. Cycasin, as
discussed earlier, ordinarily is activated by [-
glucosidases of intestinal microorganisms, and
for this season is ineffective in adult rats when in-
jected parenterally. However, there is a high
level of a (-glucosidase in rat intestinal mucosa at
birth and for the first few weeks of postnatal life.
Subcutaneous injection of cycasin during this
period leads to tumor induction by
methylazoxymethanol liberated by this transient
tissue enzyme (44). Since the carcinogenic
metabolite is relatively stable, the tumors in-
duced by it occur primarily in the kidney, remote
from the site of biosynthesis.
When the variables associated with
metabolism are eliminated, as when a direct-
acting alkylating agent is involved, it is often
found that not all tissues and organ systems in
which tumors are induced by such a carcinogen
are maximally susceptible in neonates. ENU in
mice, for example, when given as a single in-
traperitoneal injection was most effective in
neonates with respect to the liver, kidney,
ovaries, and nervous system, but more effective
in adults with respect to mammary gland, Har-
derian gland, stomach, and certain other tissues
(45). Age-dependent shifts in organotropism are
amplified in some cases by systemic physiologic
factors, such as endocrine activity. For example,
the mammary glands of young adult female rats
of some strains are extremely susceptible to aro-
matic hydrocarbon carcinogens and are the prin-
cipal organs affected by DMBA at this age (39).
In Vivo-In VitroBioassay Systems
The facile growth of fetal cells in tissue culture
and the development of reliable morphologic in-
dices of neoplastic transformation have provided
a methodological approach to two desirable goals
of bioassay screening for carcinogenic activity:
utilization of the high susceptibility of fetal cells
to improve sensitivity, and development of a
rapid, inexpensive in vitro test system. The
transplacental host-mediated system of DiPaolo
et al. (46), which has been further developed by
Quarles and Tennant (NCI Monograph, submitted
for publication), involves treating a pregnant
hamster with a test compound. A primary culture
is prepared from the minced fetuses of the
treated animal, and after several passages the
cultured cells are assayed for morphologic trans-
formation (production of atypical colonies on
plastic surfaces) or for ability to grow in soft
agar. A number of known strong carcinogens, in-
cluding polynuclear aromatic hydrocarbons and
nitroso compounds, have been demonstrated
positive in this system after a total elapsed time
of only a few months. Quarles and Tennant have
shown that nitroso derivatives of a number of
commonly used pesticides are also positive. The
system requires additional demonstrations of
sensitivity to relatively weak carcinogens but of-
fers great promise for a practical application of
transplacental carcinogenesis to the expensive
and time-consuming bioassay of suspected car-
cinogens.
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